Shares in Sanofi were sliding today after a double dose of bad news for its oral BTK inhibitor tolebrutinib, in development as a therapy for multiple sclerosis (MS). Along with what looks set to be ...

Forbes contributors publish independent expert analyses and insights. News and opinion about video games, television, movies and the internet. The NYT Mini is a quick and dirty version of the ...

Meta said it has secured agreements with energy companies Vistra, TerraPower and Oklo, which are working on nuclear power technologies. They're planning to work together to eventually power Meta's ...

Lee Hallman is a freelance writer for credit cards and travel rewards at Forbes Advisor. She is a source of information and inspiration for readers looking to navigate the world of travel with savvy ...

Plus is worth it if you often hit Free limits and want priority. Pro is for heavy users who need GPT-5.2 Pro and max quotas. Free is powerful, but all tools come with tighter caps. OpenAI introduced ...

Getting COVID-19 today is much less scary and more common than it was three years ago. By now, many people have had it not just once, but two, three, or even more times. Most of the time, repeat ...